Antitrust agencies recognize the need for collaboration during COVID-19 emergency
The Department of Justice and Federal Trade Commission today announced expedited procedures for reviewing the antitrust impact of joint efforts among competitors related to the novel coronavirus. The agencies specifically noted that “health care facilities may need to work together in providing resources and services to communities without access to personal protective equipment, medical supplies, or health care.”
To the extent that there is a need for guidance, the agencies said they will work to resolve all COVID-19-related requests addressing public health and safety within seven calendar days of receiving all needed information
Related News Articles
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
A CDC study released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…